Evidence map›Paper›PMID 32899248›Full record

ArticleInternational journal of molecular sciences2020

Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.

Yoon-Hee Cheon, Chang Hoon Lee, Da Hye Jeong, Sung Chul Kwak, Soojin Kim, Myeung Su Lee, Ju-Young Kim

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Pathophysiology of Osteoporosis after Spinal Cord Injury.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yoon-Hee CheonCore Research Facility Center, School of Medicine, Wonkwang University, Iksan 54538, Korea.
Chang Hoon LeeMusculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, Iksan 54538, Korea.
Da Hye JeongMusculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, Iksan 54538, Korea.
Sung Chul KwakDepartment of Anatomy, School of Medicine, Wonkwang University, Iksan 54538, Korea.
Soojin KimMusculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, Iksan 54538, Korea.
Myeung Su LeeMusculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, Iksan 54538, Korea.
Ju-Young KimMusculoskeletal and Immune Disease Research Institute, School of Medicine, Wonkwang University, Iksan 54538, Korea.ORCID 0000-0002-4493-0264
Wonkwang University · KRWonkwang University Hospital · KR

Funding

National Research Foundation of Korea NRF-2016R1D1A1B03933712National Research Foundation of Korea NRF-2019R1I1A1A01059434
6 · The paper itself

Abstract

Receptor activator of NF-κB ligand (RANKL) induces generation of intracellular reactive oxygen species (ROS), which act as second messengers in RANKL-mediated osteoclastogenesis. Dual oxidase maturation factor 1 (Duoxa1) has been associated with the maturation of ROS-generating enzymes including dual oxidases (Duox1 and Duox2). In the progression of osteoclast differentiation, we identified that only Duoxa1 showed an effective change upon RANKL stimulation, but not Duox1, Duox2, and Duoxa2. Therefore, we hypothesized that Duoxa1 could independently act as a second messenger for RANKL stimulation and regulate ROS production during osteoclastogenesis. Duoxa1 gradually increased during RANKL-induced osteoclastogenesis. Using siRNA or retrovirus transduction, we found that Duoxa1 regulated RANKL-stimulated osteoclast formation and bone resorption positively. Furthermore, knockdown of Duoxa1 decreased the RANKL-induced ROS production. During Duoxa1-related control of osteoclastogenesis, activation of tumor necrosis factor receptor-associated factor 6 (TRAF6)-mediated early signaling molecules including MAPKs, Akt, IκB, Btk, Src and PLCγ2 was affected, which sequentially modified the mRNA or protein expression levels of key transcription factors in osteoclast differentiation, such as c-Fos and NFATc1, as well as mRNA expression of osteoclast-specific markers. Overall, our data indicate that Duoxa1 plays a crucial role in osteoclastogenesis via regulating RANKL-induced intracellular ROS production and activating TRAF6-mediated signaling.

Indexed as

Gene Expression RegulationOsteogenesisAnimalsCell DifferentiationDual OxidasesMaleMiceMice, Inbred ICROsteoclastsRANK LigandReactive Oxygen SpeciesSignal TransductionTNF Receptor-Associated Factor 6Dual OxidasesDuox1 protein, mouseRANK LigandReactive Oxygen SpeciesTNF Receptor-Associated Factor 6Tnfsf11 protein, mouseTRAF6 protein, mouseDuoxa1osteoclastRANKLROSTRAF6

Identifiers

PMID32899248
PMCPMC7503776
OpenAlexW3081901350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.